Philippine Standard Time
Thursday, October 17, 2019
6:54 pm

Downloads - Publications Page



  • WHO: Report from the First Consultation of the Health and Social Protection Action Research & Knowledge Sharing (SPARKS) Networks.
  • WHO: Digital Health for the End TB Strategy: Progress Since 2015 and Future Perspectives.
  • WHO: Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care (2017 Update).
  • WHO: Ethics Guidance for the Implementation of the End TB Strategy.
  • WHO, UNICEF: Statement on the Use of Child-Friendly Fixed-Dose Combinations for the Treatment of TB in Children.
  • WHO: Chest Radiography in Tuberculosis Detection Summary of Current WHO Recommendations and Guidance on Programmatic Approaches.
  • WHO: The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis in Children and Adolescents: Interim Policy Guidance.
  • WHO: Framework of Indicators and Targets for Laboratory Strengthening Under the End TB Strategy.
  • WHO: The Ue of Molecular Line Probe Assays for the Detection of Resistance to Isoniazid and Rifampicin.
  • WHO: A Toolkit for Developing A National TB Research Plan, in Support of the Third Pillar of the End TB Strategy.
  • WHO: The Use of Loop-Mediated Isothermal Amplification (TB-LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance.
  • WHO: Target Regimen Profiles for TB Treatment.
  • WHO: The Use of Molecular Line Probe Assays for the Detection of Resistance to Second-Line Anti-Tuberculosis Drugs.- Policy Guidance.
  • WHO: Report on the WHO/TDR Consultation on Promoting Implementation/Operational Research in Countries Receiving Grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
  • WHO: Implementing the End TB Strategy: The Essentials.
  • WHO: Integrating Collaborative TB and HIV Services within a Comprehensive Package of Care for People Who Inject Drugs.
  • WHO: Report of the Global Consultation on the Programmatic Management of Latent Tuberculosis Infection.
  • WHO: Report of a WHO Consultation Meeting to Enhance the Engagement of Communities, Nongovernmental and Other Civil Society Organizations in Implementing the End TB Strategy.
  • WHO: On the Road to Ending TB: Highlights from the 30 Highest TB Burden Countries.
  • WHO: Promoting Access, Quality and Innovation to Save and Improve Lives.
  • WHO: Global Tuberculosis Report 2016.
  • WHO: A Global Action Framework for TB Research in Support of the Third Pillar of WHO’s End TB Strategy.
  • WHO: Systematic Screening for Active Tuberculosis: An Operational Guide.
  • WHO: Active Tuberculosis Drug-Safety Monitoring and Management (aDSM): Framework for Implementation.
  • WHO: Guidelines on the Management of Latent Tuberculosis Infection.
  • WHO: The Use of Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for the Diagnosis and Screening of Active Tuberculosis in People Living with HIV.
  • WHO: Digital Health for the End TB Strategy - An Agenda for Action.
  • WHO: A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities.
  • WHO: Implementing Tuberculosis Diagnostics: A Policy Framework.
  • WHO: A Situation Assessment Tool to Engage All Relevant Care Providers in Drug-Resistant Tuberculosis (DR-TB) Management at Country Level.
  • WHO: Recommendation on 36 Months Isoniazid Preventive Therapy to Adults and Adolescents Living with HIV in Resource-Constrained and High TB and HIV-Prevalence Settings: 2015 Update.
  • WHO: Framework for the Engagement of All Health Care Providers in the Management of Drug Resistant Tuberculosis.
  • WHO: Best Practices in Engagement of All Health Care Providers in the Management of Drug Resistant Tuberculosis.
  • WHO: Accelerating Progress on HIV, Tuberculosis, Malaria, Hepatitis and Neglected Tropical Diseases.
  • WHO: Scaling up of Collaborative TB/HIV Activities in Concentrated HIV Epidemic Settings.
  • WHO: Determination of Fabric Strength of Long-Lasting Insecticidal Nets.
  • WHO: Global Tuberculosis Report 2015.
  • WHO: Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.
  • WHO: Understanding and Using Tuberculosis Data.
  • WHO: Framework Towards Tuberculosis Elimination in Low-Incidence Countries.
  • WHO: ENGAGE-TB Approach: Training Manual.
  • WHO: Standards and Benchmarks for Tuberculosis Surveillance and Vital Registration Systems.
  • WHO: A Guide for Tuberculosis Patients to Quit Smoking.
  • WHO: International Standards for Tuberculosis Care. 3rd Edition.
  • WHO: Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children 2nd Edition.
  • WHO: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children.
  • WHO: Childhood TB.
  • WHO: Framework for Conducting Reviews of Tuberculosis Programmes.
  • WHO: High-Priority Target Product Profiles for New Tuberculosis Diagnostics.
  • WHO: Toolkit for Delivering the 5A’s and 5R’s Brief Tobacco Interventions to TB Patients in Primary Care.
  • WHO: Policy Implementation Package for New TB Drug Introduction.
  • WHO: The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis.
  • WHO: Management of Drug-Resistant Tuberculosis: Training for Staff Working at DR-TB Management Centres.
  • WHO: Caring for the Sick Child in the Community, Adaptation for High HIV or TB Settings.
  • WHO: Xpert MTB/RIF Implementation Manual.
  • WHO: Management of Tuberculosis.
  • WHO: Global Tuberculosis Report 2014.
  • WHO: Philippines PMDT Review Mission Report 2014.
  • WHO: Nutritional Care and Support for Patients with Tuberculosis.
  • WHO: Definitions and Reporting Framework for Tuberculosis.
  • WHO: Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care (2017 update).
  • WHO: Priorities for Tuberculosis Research.
  • WHO: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children.
  • WHO: Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children.
  • WHO: ENGAGE-TB Approach: Implementation manual.
  • WHO: Systematic Screening for Active Tuberculosis.
  • WHO: The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis.
  • WHO: Roadmap for Childhood TB: Toward Zero Deaths.
  • WHO: The Use of Molecular Line Probe Assay for the Detection of Resistance to Second-line Anti-Tuberculosis Drugs.
  • WHO: Joint Meeting of the Global GLC Committee and the MDR-TB Core Group.
  • WHO: The Use of a Commercial Loop-Mediated Isothermal Amplification Assay (TB-lamp) for the Detection of Tuberculosis.
  • WHO: Three Interlinked Patient Monitoring Systems for HIV and TB/HIV:.
  • WHO: Global Policy Review of Antiretroviral Therapy Eligibility Criteria for Treatment and Prevention of HIV and Tuberculosis in Adults, Pregnant Women, and Serodiscordant Couples.
  • WHO: Global Tuberculosis Report 2013.
  • WHO: WHO Drug Information.
  • WHO: WHO Drug Information.
  • WHO, UNODC, UNAIDS: WHO, UNODC, UNAIDS technical Guide for Countries to set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users – 2012 Revision.